Bilirubin attenuates the renal tubular injury by inhibition of oxidative stress and apoptosis

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Oh, Se Won ^a   Lee, Eun Seong ^b   Kim, Sejoong ^b,c   Na, Ki Young ^b,c   Chae, Dong Wan ^b,c   Kim, Suhnggwon ^c,d   Chin, Ho Jun ^b,c,d  

^a Eulji General Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

Apoptosis; Bilirubin; Cyclosporine; Oxidative stress; Renal injury

Indexed keywords

BILIRUBIN; CASPASE 3; CASPASE 9; CYCLOSPORIN A; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY EPITHELIUM; KIDNEY TUBULE DAMAGE; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; BILIRUBIN; CELL LINE; HUMANS; INJECTIONS, INTRAPERITONEAL; KIDNEY TUBULES; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84877811017     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-105     Document Type: Article

References (52)

1. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Schwertner HA, Jackson WG, Tolan G, Clin Chem 1994 40 18 23 8287538
2. Low serum bilirubin level as an independent predictor of stroke incidence: a prospective study in Korean men and women. Kimm H, Yun JE, Jo J, Jee SH, Stroke 2009 40 3422 3427 10.1161/STROKEAHA.109.560649 19713538
3. Serum total bilirubin level and prevalent lower extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Perlstein TS, Pande RL, Beckman JA, Creager MA, Arterioscler Thromb Vasc Biol 2008 28 166 172 17975120
4. Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney. Adin CA, Croker BP, Agarwal A, Am J Physiol Renal Physiol 2005 288 778 F784 15561977
5. Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. Fujii M, Inoguchi T, Sasaki S, Maeda Y, Zheng J, Kobayashi K, Takayanagi R, Kidney Int 2010 78 905 919 10.1038/ki.2010.265 20686447
6. Heme oxygenase-1 protects against radiocontrast-induced acute kidney injury by regulating anti-apoptotic proteins. Goodman AI, Olszanecki R, Yang LM, Quan S, Li M, Omura S, Stec DE, Abraham NG, Kidney Int 2007 72 945 953 10.1038/sj.ki.5002447 17667987
7. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Lin JP, Vitek L, Schwertner HA, Clin Chem 2010 56 1535 1543 10.1373/clinchem.2010.151043 20693308
8. Induction of haem oxygenase as a defence against oxidative stress. Stocker R, Free Radic Res Commun 1990 9 101 112 10.3109/10715769009148577 2189794
9. Heme oxygenase and the cardiovascular-renal system. Abraham NG, Kappas A, Free Radic Biol Med 2005 39 1 25 15925276
10. Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. Lanone S, Bloc S, Foresti R, Almolki A, Taillé C, Callebert J, Conti M, Goven D, Aubier M, Dureuil B, El-Benna J, Motterlini R, Boczkowski J, FASEB J 2005 19 1890 1892 16129699
11. Heme oxygenase-1 gene expression attenuates angiotensin II-mediated DNA damage in endothelial cells. Mazza F, Goodman A, Lombardo G, Vanella A, Abraham NG, Exp Biol Med (Maywood) 2003 228 576 583
12. CO and bilirubin inhibit doxorubicin-induced cardiac cell death. Kim DS, Chae SW, Kim HR, Chae HJ, Immunopharmacol Immunotoxicol 2009 31 64 70 10.1080/08923970802354762 18756386
13. Ectopic overexpression of haem oxygenase-1 protects kidneys from carboplatin-mediated apoptosis. Sue YM, Cheng CF, Chou Y, Chang CC, Lee PS, Juan SH, Br J Pharmacol 2011 162 1716 1730 10.1111/j.1476-5381.2010.01189.x 21198546
14. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity. Pérez-Rojas J, Blanco JA, Cruz C, Trujillo J, Vaidya VS, Uribe N, Bonventre JV, Gamba G, Bobadilla NA, Am J Physiol Renal Physiol 2007 292 131 F139 16835406
15. Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease. Bertocchio JP, Warnock DG, Jaisser F, Kidney Int 2011 79 1051 1060 10.1038/ki.2011.48 21412221
16. Cyclosporin A-induced hydrogen peroxide synthesis by cultured human mesangial cells is blocked by exogenous antioxidants. Pérez de Lema G, Arribas I, Prieto A, Parra T, de Arriba G, Rodríguez-Puyol D, Rodríguez-Puyol M, Life Sci 1998 62 1745 1753 10.1016/S0024-3205(98) 00136-2 9585105
17. Spirulina attenuates cyclosporine-induced nephrotoxicity in rats. Khan M, Shobha JC, Mohan IK, Rao Naidu MU, Prayag A, Kutala VK, J Appl Toxicol 2006 26 444 451 10.1002/jat.1159 16858688
18. Cyclosporin A disrupts bradykinin signaling through superoxide. Vetter M, Chen ZJ, Chang GD, Che D, Liu S, Chang CH, Hypertension 2003 41 1136 1142 10.1161/01.HYP.0000068201.48340.3B 12695417
19. Paricalcitol attenuates cyclosporine-induced kidney injury in rats. Park JW, Bae EH, Kim IJ, Ma SK, Choi C, Lee J, Kim SW, Kidney Int 2010 77 1076 1085 10.1038/ki.2010.69 20237458
20. CrmA gene transfer rescued CsA-induced renal cell apoptosis in graft kidney. Xiao Z, Shan J, Li C, Luo L, Feng L, Lu J, Li S, Long D, Li Y, Cell Immunol 2010 265 6 8 10.1016/j.cellimm.2010.06.012 20708731
21. Mechanisms of renal cell apoptosis induced by cyclosporine A: a systematic review of in vitro studies. Xiao Z, Li C, Shan J, Luo L, Feng L, Lu J, Li S, Long D, Li Y, Am J Nephrol 2011 33 558 566 10.1159/000328584 21613783
22. Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals. Chin HJ, Fu YY, Ahn JM, Na KY, Kim YS, Kim S, Chae DW, Nephrol Dial Transplant 2010 25 1450 1457 10.1093/ndt/gfp695 20042400
23. Biomarkers of kidney injury. Urbschat A, Obermüller N, Haferkamp A, Biomarkers 2011 16 Suppl 1 22 S30 21707441
24. Risk of Poor Outcomes with Novel and Traditional Biomarkers at Clinical AKI Diagnosis. Hall IE, Coca SG, Perazella MA, Eko UU, Luciano RL, Peter PR, Han WK, Parikh CR, Clin J Am Soc Nephrol 2011 6 2740 2749 10.2215/CJN.04960511 22034509
25. Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease? Haurani MJ, Pagano PJ, Cardiovasc Res 2007 75 679 689 10.1016/j.cardiores.2007.06.016 17689510
26. Angiotensin II-induced reactive oxygen species and the kidney. Sachse A, Wolf G, J Am Soc Nephrol 2007 18 2439 2446 10.1681/ASN.2007020149 17687073
27. NOX enzymes and the biology of reactive oxygen. Lambeth JD, Nat Rev Immunol 2004 4 181 189 10.1038/nri1312 15039755
28. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. LeBel CP, Ischiropoulos H, Bondy SC, Chem Res Toxicol 1992 5 227 231 10.1021/tx00026a012 1322737
29. Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Barnes JL, Gorin Y, Kidney Int 2011 79 944 956 10.1038/ki.2010.516 21307839
30. Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. De Miguel C, Guo C, Lund H, Feng D, Mattson DL, Am J Physiol Renal Physiol 2011 300 734 F742 10.1152/ajprenal.00454.2010 21159736
31. NADPH oxidases in the kidney. Gill PS, Wilcox CS, Antioxid Redox Signal 2006 8 1597 1607 10.1089/ars.2006.8.1597 16987014
32. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Bedard K, Krause KH, Physiol Rev 2007 87 245 313 10.1152/physrev.00044.2005 17237347
33. A novel superoxide-producing NAD(P)H oxidase in kidney. Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakata H, Naito S, Hattori M, Sakaki Y, Sumimoto H, J Biol Chem 2001 276 1417 1423 10.1074/jbc.M007597200 11032835
34. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. Gorin Y, Ricono JM, Wagner B, Kim NH, Bhandari B, Choudhury GG, Abboud HE, Biochem J 2004 381 231 239 10.1042/BJ20031614 15027896
35. NAD(P)H oxidase mediates TGFbeta1-induced activation of kidney myofibroblasts. Bondi CD, Manickam N, Lee DY, Block K, Gorin Y, Abboud HE, Barnes JL, J Am Soc Nephrol 2010 21 93 102 10.1681/ASN.2009020146 19926889
36. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, Knaus UG, Cell Signal 2006 18 69 82 10.1016/j.cellsig.2005.03.023 15927447
37. Nox2 is a Mediator of Chronic CsA Nephrotoxicity. Djamali A, Reese S, Hafez O, Vidyasagar A, Jacobson L, Swain W, Kolehmainen C, Huang L, Wilson NA, Torrealba JR, Am J Transplant 2012 [Epub ahead of print]
38. Nox-2 is a modulator of fibrogenesis in kidney allografts. Djamali A, Vidyasagar A, Adulla M, Hullett D, Reese S, Am J Transplant 2009 9 74 82 18976289
39. Role of oxidative stress in lysosomal membrane permeabilization and apoptosis induced by gentamicin, an aminoglycoside antibiotic. Denamur S, Tyteca D, Marchand-Brynaert J, Van Bambeke F, Tulkens PM, Courtoy PJ, Mingeot-Leclercq MP, Free Radic Biol Med 2011 51 1656 1665 10.1016/j.freeradbiomed.2011.07.015 21835240
40. Nano-copper induces oxidative stress and apoptosis in kidney via both extrinsic and intrinsic pathways. Sarkar A, Das J, Manna P, Sil PC, Toxicology 2011 290 208 217 10.1016/j.tox.2011.09.086 22000994
41. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, Maruyama Y, Arterioscler Thromb Vasc Biol 2005 25 155 160 15499042
42. Cytoprotective role of heme oxygenase (HO)-1 in human kidney with various renal diseases. Morimoto K, Ohta K, Yachie A, Yang Y, Shimizu M, Goto C, Toma T, Kasahara Y, Yokoyama H, Miyata T, Seki H, Koizumi S, Kidney Int 2001 60 1858 1866 10.1046/j.1523-1755.2001.01000.x 11703604
43. Intracellular accumulation of bilirubin as a defense mechanism against increased oxidative stress. Zelenka J, Muchova L, Zelenkova M, Vanova K, Vreman HJ, Wong RJ, Vitek L, Biochimie 2012 94 1821 1827 10.1016/j.biochi.2012.04.026 22580386
44. TGF-beta signaling in renal disease. Böttinger EP, Bitzer M, J Am Soc Nephrol 2002 13 2600 2610 10.1097/01.ASN.0000033611.79556.AE 12239251
45. Mechanisms of renal apoptosis in health and disease. Sanz AB, Santamaría B, Ruiz-Ortega M, Egido J, Ortiz A, J Am Soc Nephrol 2008 19 1634 1642 10.1681/ASN.2007121336 18632846
46. Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. Justo P, Lorz C, Sanz A, Egido J, Ortiz A, J Am Soc Nephrol 2003 14 3072 3080 10.1097/01.ASN.0000099383.57934.0E 14638906
47. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P, Lancet 2005 365 1231 1238 10.1016/S0140-6736(05)74811-X 15811456
48. Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. Prozialeck WC, Edwards JR, Lamar PC, Liu J, Vaidya VS, Bonventre JV, Toxicol Appl Pharmacol 2009 238 306 314 10.1016/j.taap.2009.01.016 19371613
49. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV, J Clin Invest 2008 118 1657 1668 10.1172/JCI34487 18414680
50. Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells. Nelson AM, Zhao W, Gilliland KL, Zaenglein AL, Liu W, Thiboutot DM, J Clin Invest 2008 118 1468 1478 10.1172/JCI33869 18317594
51. Polymerized type I collagen reduces chronic cyclosporine nephrotoxicity. Sánchez-Pozos K, Lee-Montiel F, Pérez-Villalva R, Uribe N, Gamba G, Bazan-Perkins B, Bobadilla NA, Nephrol Dial Transplant 2010 25 2150 2158 10.1093/ndt/gfq020 20139407
52. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Wasilewska A, Zoch-Zwierz W, Taranta-Janusz K, Michaluk-Skutnik J, Pediatr Nephrol 2010 25 889 897 10.1007/s00467-009-1397-1 20072790